Table 2.
Demographic and clinical characteristics of cohort 2.
| Cohort 2 | ASD | DF | DHF | DSS | Overall |
|---|---|---|---|---|---|
| (N = 8) | (N = 13) | (N = 13) | (N = 6) | (N = 40) | |
| Age | |||||
| Mean (SD) | 10.0 (4.1) | 8.68 (3.3) | 9.23 (3.1) | 10.7 (3.5) | 9.43 (3) |
| Gender | |||||
| Female | 3 (38%) | 7 (54%) | 6 (46%) | 2 (33%) | 18 (45%) |
| Male | 5 (62%) | 6 (46%) | 7 (53%) | 4 (66%) | 22 (55%) |
| Serotype | |||||
| DENV-1 | 8 (100%) | 13 (100%) | 12 (92.3%) | 4 (66.7%) | 37 (92.5%) |
| Undetermined | 0 (0%) | 0 (0%) | 1 (7.7%) | 2 (33.3%) | 3 (7.5%) |
| Immune Status | |||||
| Primary | 4 (50.0%) | 6 (46.2%) | 0 (0%) | 0 (0%) | 10 (25.0%) |
| Secondary | 4 (50.0%) | 7 (53.8%) | 13 (100%) | 6 (100%) | 30 (75.0%) |
| Day of Fever | |||||
| Mean (SD) | NA | 3.6 (1.3) | 4.5 (0.8) | 4.3 (0.5) | 4.1 (1.1) |
| Viral load | |||||
| Mean (SD) | 5.99E + 03 (1.06E + 03) | 5.75E + 07 (9.1E + 07) | 1.18E + 07 (7.27E + 04) | 2.28E + 04 (2.73E + 04) | 2.47E + 07 (6.13E + 07) |
| Day of Sampling | |||||
| Mean (SD) | 7.00 (0) | 7.00 (0) | 7.00 (0) | 7.00 (0) | 7.00 (0) |
NA: not applicable.